We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
1951
Palvella Therapeutics
PVLA
$1.98B
| $294K | ﹤0.01% |
+487
| New | +$226K |
|
|
LBY
1952
DELISTED
Libbey, Inc.
LBY
| $293K | ﹤0.01% |
38,941
-32,800
| -46% | -$256K |
|
1953
Laureate Education
LAUR
$5.18B
| $290K | ﹤0.01% |
+21,400
| New | +$280K |
|
|
VSTO
1954
DELISTED
Vista Outdoor Inc.
VSTO
| $290K | ﹤0.01% |
19,928
-60,700
| -75% | -$1.06M |
|
1955
Ericsson
ERIC
$30.7B
| $289K | ﹤0.01% |
43,300
-69,300
| -62% | -$432K |
|
|
ALTR
1956
DELISTED
Altair Engineering Inc
ALTR
| $287K | ﹤0.01% |
+12,000
| New | +$267K |
|
1957
ePlus
PLUS
$2.33B
| $286K | ﹤0.01% |
7,616
-2,200
| -22% | -$92.7K |
|
1958
VSE Corp
VSEC
$5.48B
| $286K | ﹤0.01% |
5,900
-100
| -2% | -$5.13K |
|
|
FMI
1959
DELISTED
Foundation Medicine, Inc.
FMI
| $286K | ﹤0.01% |
+4,200
| New | +$218K |
|
1960
Amtech Systems
ASYS
$278M
| $284K | ﹤0.01% |
+28,200
| New | +$345K |
|
1961
Genco Shipping & Trading
GNK
$1.17B
| $282K | ﹤0.01% |
+21,200
| New | +$254K |
|
|
CVA
1962
DELISTED
Covanta Holding Corporation
CVA
| $282K | ﹤0.01% |
16,686
-126,200
| -88% | -$1.95M |
|
|
PCMI
1963
DELISTED
PCM, Inc
PCMI
| $282K | ﹤0.01% |
28,500
+2,200
| +8% | +$25.3K |
|
1964
Standex International
SXI
$3.68B
| $281K | ﹤0.01% |
+2,763
| New | +$285K |
|
1965
Strategic Education
STRA
$1.71B
| $279K | ﹤0.01% |
3,111
+200
| +7% | +$18.5K |
|
1966
Xencor
XNCR
$1.44B
| $278K | ﹤0.01% |
+12,700
| New | +$275K |
|
|
TGB
1967
Trekor Metals
TGB
$2.56B
| $277K | ﹤0.01% |
118,700
+69,800
| +143% | +$151K |
|
1968
HealthStream
HSTM
$793M
| $276K | ﹤0.01% |
11,920
+300
| +3% | +$7.06K |
|
1969
World Acceptance Corp
WRLD
$950M
| $275K | ﹤0.01% |
3,409
-6,500
| -66% | -$523K |
|
|
CHUY
1970
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $275K | ﹤0.01% |
9,800
-3,200
| -25% | -$75.7K |
|
|
PHIIK
1971
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $275K | ﹤0.01% |
23,731
| – | – |
|
|
CMBT
1972
CMB.TECH NV
CMBT
$4.57B
| $274K | ﹤0.01% |
29,621
+2,800
| +10% | +$23.6K |
|
|
VOXX
1973
DELISTED
VOXX International Corporation Class A
VOXX
| $274K | ﹤0.01% |
48,969
-17,800
| -27% | -$116K |
|
1974
Natural Health Trends
NHTC
$15.4M
| $273K | ﹤0.01% |
18,000
+6,400
| +55% | +$121K |
|
1975
SiriusXM
SIRI
$10B
| $273K | ﹤0.01% |
+5,087
| New | +$281K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.